These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7486588)

  • 1. Localization of protease activity in antibody subunits.
    Sun M; Li L; Gao QS; Paul S
    Ann N Y Acad Sci; 1995 Sep; 764():573-5. PubMed ID: 7486588
    [No Abstract]   [Full Text] [Related]  

  • 2. Substrate-driven formation of a proteolytic antibody light chain.
    Gao QS; Sun M; Tyutyulkova S; Webster D; Rees A; Tramontano A; Massey RJ; Paul S
    Ann N Y Acad Sci; 1995 Sep; 764():567-9. PubMed ID: 7486586
    [No Abstract]   [Full Text] [Related]  

  • 3. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
    Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S
    J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered cleavage site preference of a proteolytic antibody light chain induced by denaturation.
    Sun M; Paul S
    FEBS Lett; 1997 May; 407(3):289-90. PubMed ID: 9175870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface.
    Okochi N; Kato-Murai M; Kadonosono T; Ueda M
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):597-603. PubMed ID: 17899065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1.
    Hifumi E; Okamoto Y; Uda T
    Appl Biochem Biotechnol; 2000; 83(1-3):209-19; discussion 219-20, 297-313. PubMed ID: 10826961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new algorithm to convert a normal antibody into the corresponding catalytic antibody.
    Hifumi E; Taguchi H; Tsuda H; Minagawa T; Nonaka T; Uda T
    Sci Adv; 2020 Mar; 6(13):eaay6441. PubMed ID: 32232151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic activity of antibody light chain to gp41: a consideration of refolding in relation to activation mechanism.
    Uda T; Hifumi E; Ohara K; Zhou Y
    Chem Immunol; 2000; 77():18-32. PubMed ID: 11706704
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoantibody catalysis: no longer hostage to Occam's razor.
    Paul S
    Ann N Y Acad Sci; 1998 Dec; 865():238-46. PubMed ID: 9928017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of catalytic activity by EDTA from antibody light chain.
    Hifumi E; Ohara K; Niimi Y; Uda T
    Biometals; 2000 Dec; 13(4):289-94. PubMed ID: 11247034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human germ line antibody light chain with hydrolytic properties associated with multimerization status.
    Sharma V; Heriot W; Trisler K; Smider V
    J Biol Chem; 2009 Nov; 284(48):33079-87. PubMed ID: 19801545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic activity of an antibody light chain.
    Sun M; Gao QS; Li L; Paul S
    J Immunol; 1994 Dec; 153(11):5121-6. PubMed ID: 7963569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of a proteolytic antibody light chain.
    Gao QS; Sun M; Tyutyulkova S; Webster D; Rees A; Tramontano A; Massey RJ; Paul S
    J Biol Chem; 1994 Dec; 269(51):32389-93. PubMed ID: 7798238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endopeptidase character of monoclonal antibody i41-7 subunits.
    Hatiuchi K; Hifumi E; Mitsuda Y; Uda T
    Immunol Lett; 2003 May; 86(3):249-57. PubMed ID: 12706527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed mutagenesis of proteolytic antibody light chain.
    Gao QS; Sun M; Rees AR; Paul S
    J Mol Biol; 1995 Nov; 253(5):658-64. PubMed ID: 7473741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic digestion of human tumor necrosis factor-α by antibody heavy chain.
    Hifumi E; Higashi K; Uda T
    FEBS J; 2010 Sep; 277(18):3823-32. PubMed ID: 20718866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies.
    Paul S
    Appl Biochem Biotechnol; 1994; 47(2-3):241-53; discussion 253-5. PubMed ID: 7944341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide hydrolysis by antibody light chains.
    Mei S; Mody B; Eklund SH; Paul S
    J Biol Chem; 1991 Aug; 266(24):15571-4. PubMed ID: 1908455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.